All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-ZP136 | Anti-FVIII (X7X174) h(CD28-CD3ζ) CAR, pCDCAR1 | human | X7X174 | human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP137 | Anti-FVIII (X7X174) h(41BB-CD3ζ) CAR, pCDCAR1 | human | X7X174 | human | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAART-LX065 | Anti-FVIII h(X7X173) h(CD28-CD3ζ) CAART, pCDCAAR1 | human | X7X173 | human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX066 | Anti-FVIII h(X7X173) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | human | X7X173 | human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
XS-0722-LX173 | Anti-FVIII (X7X173) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | human | X7X173 | human | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
XS-0722-LX174 | Anti-FVIII (X7X174) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | human | X7X174 | human | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
XS-0722-LX175 | Anti-FVIII (X7X175) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | human | X7X175 | human | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
XS-0722-LX176 | Anti-FVIII (X7X176) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | human | X7X176 | human | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
XS-0722-LX183 | Anti-FVIII (X7X183) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | human | X7X183 | Mouse | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
XS-0722-LX184 | Anti-FVIII (X7X184) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | human | X7X184 | Mouse | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
XS-0722-LX382 | Anti-FVIII (X7X174) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | human | X7X174 | human | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-LX800 | Anti-FVIII (X7X176) h(CD28-41BB-CD3ζ) CAR, pMMLV | human | X7X176 | human | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0722-LX801 | Anti-FVIII (X7X177) h(CD28-41BB-CD3ζ) CAR, pMMLV | human | X7X177 | human | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0722-LX804 | Anti-FVIII (YK3.3.50) h(CD28-41BB-CD3ζ) CAR, pMMLV | human | YK3.3.50 | Mouse | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0722-LX805 | Anti-FVIII (X7X181) h(CD28-41BB-CD3ζ) CAR, pMMLV | human | X7X181 | Mouse | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0722-LX806 | Anti-FVIII (X7X182) h(CD28-41BB-CD3ζ) CAR, pMMLV | human | X7X182 | Mouse | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0722-LX807 | Anti-FVIII (X7X183) h(CD28-41BB-CD3ζ) CAR, pMMLV | human | X7X183 | Mouse | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0722-LX808 | Anti-FVIII (X7X184) h(CD28-41BB-CD3ζ) CAR, pMMLV | human | X7X184 | Mouse | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0722-LX809 | Anti-FVIII (X7X185) h(CD28-41BB-CD3ζ) CAR, pMMLV | human | X7X185 | Mouse | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0722-LX810 | Anti-FVIII (X7X186) h(CD28-41BB-CD3ζ) CAR, pMMLV | human | X7X186 | Mouse | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION